Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 4, 2003, Pages 496-521

  Auvinen, Merja ^a,b   Järvinen, Kristiina ^a   Hotti, Anneli ^a   Okkeri, Juha ^b   Laitinen, Jens ^a   Jänne, Olli A ^c   Coffino, Philip ^d   Bergman, Mathias ^b   Andersson, Leif C ^a   Alitalo, Kari ^a   Hölttä, Erkki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; C Myc; Ornithine decarboxylase; Retinoblastoma; Transformation; Tumor suppresser

Indexed keywords

ORNITHINE DECARBOXYLASE; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL STRAIN COS7; CELL TRANSFORMATION; CERCOPITHECIDAE; CONTROLLED STUDY; DNA FLANKING REGION; EMBRYO; FEMALE; FIBROBLAST; GENE CONTROL; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; INTRON; MOUSE; NONHUMAN; ONCOGENE C H RAS; ONCOGENE C MYC; PROTEIN EXPRESSION; PROTEIN INTERACTION; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BINDING SITES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, MYC; HELA CELLS; HUMANS; MADS DOMAIN PROTEINS; MICE; ORNITHINE DECARBOXYLASE; RETINOBLASTOMA PROTEIN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

MURINAE;

EID: 0037385070     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00305-9     Document Type: Article

References (95)

1. Alm K., Berntsson P.S., Kramer D.L., Porter C.W., Oredsson S.M. Treatment of cells with the polyamine analog N, N11-diethylnorspermine retards S phase progression within one cell cycle. European Journal of Biochemistry. 267:2000;4157-4164.
2. Amati B., Brooks M.W., Levy N., Littlewood T.D., Evan G.I., Land H. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell. 72:1993;233-245.
3. Amin C., Wagner A.J., Hay N. Sequence-specific transcriptional activation by Myc and repression by Max. Molecular and Cellular Biology. 13:1993;383-390.
4. Auvinen M., Laine A., Paasinen-Sohns A., Kangas A., Kangas L., Saksela O., Andersson L.C., Hölttä E. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Research. 57:1997;3016-3025.
5. Auvinen M., Paasinen A., Andersson L.C., Hölttä E. Ornithine decarboxylase activity is critical for cell transformation. Nature. 360:1992;355-358.
6. Auvinen M., Paasinen-Sohns A., Hirai H., Andersson L.C., Hölttä E. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS. Molecular and Cellular Biology. 15:1995;6513-6525.
7. Ayer D.E., Kretzner L., Eisenman R.N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell. 72:1993;211-222.
8. Barrett J., Birrer M.J., Kato G.J., Dosaka-Akita H., Dang C.V. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Molecular and Cellular Biology. 12:1992;3130-3137.
9. Beijersbergen R.L., Hijmans E.M., Zhu L., Bernards R. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO Journal. 13:1994;4080-4086.
10. Bello-Fernandez C., Packham G., Cleveland J.L. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;7804-7808.
11. Blackwell T.K., Kretzner L., Blackwood E.M., Eisenman R.N., Weintraub H. Sequence-specific DNA binding by the c-Myc protein. Science. 250:1990;1149-1151.
12. Blackwood E.M., Luscher B., Eisenman R.N. Myc and Max associate in vivo. Genes and Development. 6:1992;71-80.
13. Blackwood E.M., Eisenman R.N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science. 251:1991;1211-1217.
14. Bouchard C., Thieke K., Maies A., Saffrich R., Hanley-Hyde J., Ansorge W., Reed S., Sicinski P., Bartek J., Eilesa M. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO Journal. 18:1999;5321-5333.
15. Brabant M., McConlogue L., van Daalen Wetters T., Coffino P. Mouse ornithine decarboxylase gene: cloning, structure, and expression. Proceedings of the National Academy of Science U.S.A. 85:1988;2200-2204.
16. Bush A., Mateyak M., Dugan K., Obaya A., Adachi S., Sedivy J., Cole M. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes and Development. 12:1998;3797-3802.
17. Chittenden T., Livingston D.M., Kaelin W.G. Jr. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell. 65:1991;1073-1082.
18. Cole M.D., McMahon S.B. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene. 18:1999;2916-2924.
19. Coller H.A., Grandori C., Tamayo P., Colbert T., Lander E.S., Eisenman R.N., Golub T.R. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;3260-3265.
20. Collins S.J., Ruscetti F.W., Gallagher R.E., Gallo R.C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proceedings of the National Academy of Sciences of the United States of America. 75:1978;2458-2462.
21. Conzen S.D., Gottlob K., Kandel E.S., Khanduri P., Wagner A.J., O'Leary M., Hay N. Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Molecular and Cellular Biology. 20:2000;6008-60018.
22. Dang C.V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Molecular and Cellular Biology. 19:1999;1-11.
23. Eilers M., Picard D., Yamamoto K.R., Bishop J.M. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature. 340:1989;66-68.
24. Fredlund J.O., Johansson M.C., Dahlberg E., Oredsson S.M. Ornithine decarboxylase and S-adenosylmethionine decarboxylase expression during the cell cycle of Chinese hamster ovary cells. Experimental Cell Research. 216:1995;86-92.
25. Galaktionov K., Chen X., Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature. 382:1996;511-517.
26. Gilmour S.K., Birchler M., Smith M.K., Rayca K., Mostochuk J. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin. Cell Growth and Differentiation. 10:1999;739-748.
27. Goodrich D.W., Wang N.P., Qian Y.W., Lee E.Y., Lee W.H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell. 67:1991;293-302.
28. Goodrich D.W., Lee W.H. Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53. Nature. 360:1992;177-179.
29. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences of the United States of America. 89:1992;5547-5551.
30. Grandori C., Mac J., Siebelt F., Ayer D.E., Eisenman R.N. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO Journal. 15:1996;4344-4357.
31. Grandori C., Cowley S.M., James L.P., Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annual Review of Cell and Developmental Biology. 16:2000;653-699.
32. Greenberg M.E., Ziff E.B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 311:1984;433-438.
33. Gu W., Bhatia K., Magrath I.T., Dang C.V., Dalla-Favera R. Binding and suppression of the Myc transcriptional activation domain by p107. Science. 264:1994;251-254.
34. Gu W., Cechova K., Tassi V., Dalla-Favera R. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;2935-2939.
35. Heby O., Persson L. Molecular genetics of polyamine synthesis in eukaryotic cells. Trends in Biochemical Sciences. 15:1990;153-158.
36. Henriksson M., Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Advances in Cancer Research. 68:1996;109-182.
37. Hermeking H., Rago C., Schnhmacher M., Li Q., Barrett J.F., Obaya A.J., O'Connell B.C., Matayek M.K., Tam W., Kohlhuber F., Dana C.V., Sedivy J.M., Eick D., Vogelstein B., Kinzles K.W. Identification of CDK4 as a target of c-MYC. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;2229-2234.
38. Hickok N.J., Wahlfors J., Crozat A., Halmekytö M., Alhonen L., Jänne J., Jänne O.A. Human ornithine decarboxylase-encoding loci: nucleotide sequence of the expressed gene and characterization of a pseudogene. Gene. 93:1990;257-263.
39. Hölttä E., Sistonen L., Alitalo K. The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. Journal of Biological Chemistry. 263:1988;4500-4507.
40. Hölttä E., Auvinen M., Andersson L.C. Polyamines are essential for cell transformation by pp60v-src: delineation of molecular events relevant for the transformed phenotype. Journal of Cell Biology. 122:1993;903-914.
41. Horowitz J.M., Parh S.H., Bogenmann E., Cherg J.C., Dandell D.W., Kanje F.J., Minna J.D., Drzja T.P., Weinberg R.A. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 87:1990;2775-2779.
42. Hotti, A. (2000). Caspases in c-Myc-induced apoptosis, Academic Dissertation. University of Helsinki.
43. Iyengar R.V., Pawlik C.A., Krull E.J., Phelps D.A., Burger R.A., Harris L.C., Potter P.M., Danks M.K. Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression. Cancer Research. 61:2001;3045-3052.
44. Jones R.M., Branda J., Johnston K.A., Polymenis M., Gadd M., Rustgi A., Callanan L., Schmidt E.V. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Molecular and Cellular Biology. 16:1996;4754-4764.
45. Kangas A., Nicholson D.W., Hölttä E. Involvement of CPP32/caspase-3 in c-Myc-induced apoptosis. Oncogene. 16:1998;387-398.
46. Kato G.J., Barrett J., Villa-Garcia M., Dang C.V. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Molecular and Cellular Biology. 10:1990;5914-5920.
47. Kato G.J., Lee W.M., Chen L.L., Dang C.V. Max: functional domains and interaction with c-Myc. Genes and Development. 6:1992;81-92.
48. Katz A., Kahana C. Isolation and characterization of the mouse ornithine decarboxylase gene. Journal of Biological Chemistry. 263:1988;7604-7609.
49. Koskinen P.J., Västrik I., Mäkelä T.P., Eisenman R.N., Alitalo K. Max activity is affected by phosphorylation at two NH2-terminal sites. Cell Growth and Differentiation. 5:1994;313-320.
50. Koskinen P.J., Sistonen L., Evan G., Morimoto R., Alitalo K. Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells. Journal of Virology. 65:1991;842-851.
51. Kramer D.L., Chang B.D., Chen Y., Diegelman P., Alm K., Black A.R., Roninson I.B., Porter C.W. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Cancer Research. 61:2001;7754-7762.
52. Kretzner L., Blackwood E.M., Eisenman R.N. Myc and Max proteins possess distinct transcriptional activities. Nature. 359:1992;426-429.
53. Kubota S., Kiyosawa H., Nomura Y., Yamada T., Seyama Y. Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion. Journal of the National Cancer Institute. 89:1997;567-571.
54. Laitinen J., Samarut J., Hölttä E. A nontoxic and versatile protein salting-out method for isolation of DNA. Biotechniques. 17:1994;316-322.
55. Laitinen J., Stenius K., Eloranta T.O., Hölttä E. Polyamines may regulate S-phase progression but not the dynamic changes of chromatin during the cell cycle. Journal of Cellular Biochemistry. 68:1998;200-212.
56. Li L.H., Nerlov C., Prendergast G., MacGregor D., Ziff E.B. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO Journal. 13:1994;4070-4079.
57. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Research. 23:1995;1686-1690.
58. Maheswaran S., Lee H., Sonenshein G.E. Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein. Molecular and Cellular Biology. 14:1994;1147-1152.
59. Mäkelä T.P., Koskinen P.J., Västrik I., Alitalo K. Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation. Science. 256:1992;373-377.
60. Marcu K.B., Bossone S.A., Patel A.J. Myc function and regulation. Annual Review of Biochemistry. 61:1992;809-860.
61. McMahon S.B., Van Buskirk H.A., Dugan K.A., Copeland T.D., Cole M.D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell. 94:1998;363-374.
62. Megosh L., Gilmour S.K., Rosson D., Soler A.P., Blessing M., Sawicki J.A., O'Brien T.G. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Research. 55:1995;4205-4209.
63. Meyskens F.L. Jr., Gerner E.W. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clinical Cancer Research. 5:1999;945-951.
64. Mittnacht S., Weinberg R.A. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell. 65:1991;381-393.
65. Mol P.C., Wang R.H., Batey D.W., Lee L.A., Dang C.V., Berger S.L. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene. Molecular and Cellular Biology. 15:1995;6999-7009.
66. Morgenstern J.P., Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Research. 18:1990;3587-3596.
67. Moshier J.A., Dosescu J., Skunca M., Luk G.D. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Research. 53:1993;2618-2622.
68. Mukherjee B., Morgenbesser S.D., DePinho R.A. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes and Development. 6:1992;1480-1492.
69. O'Brien T.G., Megosh L.C., Gilliard G., Soler A.P. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Research. 57:1997;2630-2637.
70. O'Hagan R.C., Schreiber-Agus N., Chen K., David S., Engelman J.A., Schwab R., Alland L., Thomson C., Ronning D.R., Sacchettini J.C., Meltzer P., DePinho R.A. Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nature Genetics. 24:2000;113-119.
71. Packham G., Porter C.W., Cleveland J.L. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene. 13:1996;461-469.
72. Packham G., Cleveland J.L. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Molecular and Cellular Biology. 14:1994;5741-5747.
73. Palvimo J.J., Eisenberg L.M., Jänne O.A. Protein-DNA interactions in the cAMP responsive promoter region of the murine ornithine decarboxylase gene. Nucleic Acids Research. 19:1991;3921-3927.
74. Pegg A.E., Shantz L.M., Coleman C.S. Ornithine decarboxylase as a target for chemoprevention. Journal of Cellular Biochemistry Supplements. 22:1995;132-138.
75. Pena A., Reddy C.D., Wu S., Hickok N.J., Reddy E.P., Yumet G., Soprano D.R., Soprano K.J. Regulation of human ornithine decarboxylase expression by the c-Myc Max protein complex. Journal of Biological Chemistry. 268:1993;27277-27285.
76. Perez-Roger I., Kim S.H., Griffiths B., Sewing A., Land H. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO Journal. 18:1999;5310-5320.
77. Pohjanpelto P., Hölttä E. Phosphorylation of Okazaki-like DNA fragments in mammalian cells and role of polyamines in the processing of this DNA. EMBO Journal. 15:1996;1193-1200.
78. Ravanko K., Järvinen K., Paasinen-Sohns A., Hölttä E. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes. Cancer Research. 60:2000;5244-5253.
79. Robbins P.D., Horowitz J.M., Mulligan R.C. Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature. 346:1990;668-671.
80. Rustgi A.K., Dyson N., Bernards R. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature. 352:1991;541-544.
81. Sakamuro D., Prendergast G.C. New Myc-interacting proteins: a second Myc network emerges. Oncogene. 18:1999;2942-2954.
82. Sambrook, J., Fritch E.F., Maniatis T., 1989. Molecular cloning: A laboratory manual (2nd ed.). NY: Cold Spring Harbor Laboratory Press.
83. Shantz L.M., Coleman C.S., Pegg A.E. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation. Cancer Research. 56:1996;5136-5140.
84. Smith M.K., Goral M.A., Wright J.H., Matrisian L.M., Morris R.J., Klein-Szanto A.J., Gilmour S.K. Ornithine decarboxylase overexpression leads to increased epithelial tumor invasiveness. Cancer Research. 57:1997;2104-2108.
85. Stone J., de Lange T., Ramsay G., Jakobovits E., Bishop J.M., Varmus H., Lee W. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Molecular and Cellular Biology. 7:1987;1697-1709.
86. Tavtigian S.V., Zabludoff S.D., Wold B.J. Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. Molecular Biology of the Cell. 5:1994;375-388.
87. Tobias K.E., Shor J., Kahana C. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs. Oncogene. 11:1995;1721-1727.
88. Torres R., Schreiber-Agus N., Morgenbesser S.D., DePinho R.A. Myc and Max: a putative transcriptional complex in search of a cellular target. Current Opinion in Cellular Biology. 4:1992;468-474.
89. van Daalen Wetters T., Brabant M., Coffino P. Regulation of mouse ornithine decarboxylase activity by cell growth, serum and tetradecanoyl phorbol acetate is governed primarily by sequences within the coding region of the gene. Nucleic Acids Research. 17:1989;9843-9860.
90. van Steeg H., van Oostrom C.T., Hodemaekers H.M., van Kreyl C.F. Cloning and functional analysis of the rat ornithine decarboxylase-encoding gene. Gene. 93:1990;249-256.
91. Västrik I., Kaipainen A., Penttilä T.L., Lymboussakis A., Alitalo R., Parvinen M., Alitalo K. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. Journal of Cell Biology. 128:1995;1197-1208.
92. Wagner A.J., Meyers C., Laimins L.A., Hay N. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth and Differentiation. 4:1993;879-883.
93. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
94. Wu K.J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nature Genetics. 21:1999;220-224.
95. Wu S., Pena A., Korcz A., Soprano D.R., Soprano K.J. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Oncogene. 12:1996;621-629.